Dr. Berenson Discusses Early Phase Proteasome Inhibitors

onclivetv has 407 videos Subscribe Here

Description: Visit to View More Videos

James R. Berenson, MD, Medical and Scientific Director, Institute for Myeloma & Bone Cancer Research (IMBCR), Chief Executive Officer, Oncotherapeutics, discusses 4 proteasome inhibitors that are in the early development. Some of the new agents are similar to currently approved agents, such as bortezomib, while others are completely unique.

For the full description visit
Shared By : onclivetv
Posted on : 01/17/12
Added : 6 years ago
Category : Other


Nothing found.

More From onclivetv

Nothing found.